Topic

North Carolina

A collection of 524 issues

How to Get Helixate (rFVIII) Covered by Aetna CVS Health in North Carolina: Complete Prior Authorization Guide

Answer Box: Helixate (rFVIII) requires prior authorization from Aetna CVS Health in North Carolina. However, Helixate and Kogenate FS have been discontinued—you'll need to request coverage for alternatives like Advate, Kovaltry, or Jivi. Submit the Medical Exception/Prior Authorization form with complete hemophilia A documentation via Availity

How to Get Galafold (Migalastat) Covered by Cigna in North Carolina: Prior Authorization Guide and Appeal Scripts

Answer Box: Getting Galafold (Migalastat) Covered by Cigna in North Carolina Eligibility: Adults with Fabry disease and a confirmed amenable GLA variant (via genetic testing), adequate kidney function (eGFR ≥30), and specialist involvement. Fastest path: Submit prior authorization through Express Scripts/Accredo with genetic testing showing amenable variant, specialist letter,

Lowering Out-of-Pocket for Dojolvi (Triheptanoin) with Blue Cross Blue Shield in North Carolina: Copay, Tiering & Assistance

Answer Box: Getting Dojolvi Covered by Blue Cross Blue Shield in North Carolina Fastest path to approval: Submit prior authorization through your prescriber with molecular confirmation of LC-FAOD, detailed medical necessity letter, and documentation of failed alternatives. Blue Cross NC requires PA for Dojolvi (Tier 5 specialty). If denied, appeal

How to Get Takhzyro (Lanadelumab) Covered by Blue Cross Blue Shield North Carolina: Complete Timeline & Appeals Guide

Answer Box: Getting Takhzyro Covered by BCBS North Carolina Blue Cross Blue Shield North Carolina requires prior authorization for Takhzyro (lanadelumab) with decisions typically made within 3 business days. For hereditary angioedema patients, approval depends on confirmed HAE Type I/II diagnosis, documented attack frequency (≥1 attack every 4 weeks)

How to Get Brensocatib (BRINSUPRI) Covered by UnitedHealthcare in North Carolina: Prior Authorization Guide & Appeals Process

Answer Box: Getting Brensocatib (BRINSUPRI) Covered by UnitedHealthcare in North Carolina Eligibility: Patients 12+ with confirmed non-cystic fibrosis bronchiectasis and 2+ exacerbations requiring antibiotics in the past year. Fastest path: Submit prior authorization through UnitedHealthcare Provider Portal with pulmonologist evaluation, documented macrolide failure, and HRCT scan. First step today: Verify

How to Get Juxtapid (Lomitapide) Covered by Humana in North Carolina: Prior Authorization Guide & Appeal Process

Quick Answer: Juxtapid (Lomitapide) Coverage by Humana in North Carolina Yes, Humana covers Juxtapid (lomitapide) in North Carolina with prior authorization for homozygous familial hypercholesterolemia (HoFH). Key requirements: genetic confirmation of HoFH, documented failure of statins/ezetimibe/PCSK9 inhibitors, REMS program enrollment, and specialist involvement (cardiologist/endocrinologist). First step today:

How to Get Opzelura (Ruxolitinib Cream) Covered by Cigna in North Carolina: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Opzelura Covered by Cigna in North Carolina Cigna requires prior authorization for Opzelura (ruxolitinib cream) with mandatory step therapy in North Carolina. You must document failure of topical steroids (28+ days) OR calcineurin inhibitors (12+ weeks) before approval. Submit through your dermatologist via Cigna's provider

Do You Qualify for Mavenclad Coverage by Blue Cross Blue Shield in North Carolina? Complete Decision Tree & Appeals Guide

Answer Box: To qualify for Mavenclad coverage by Blue Cross Blue Shield in North Carolina, you need: confirmed relapsing MS diagnosis, documented failure of 2+ other MS therapies, normal lymphocyte count, and neurologist prescription. Submit prior authorization through the Blue Cross NC provider portal with complete clinical documentation. If denied,

How to Get Xospata (Gilteritinib) Covered by Humana in North Carolina: Prior Authorization, Appeals, and Cost-Saving Strategies

Answer Box: Getting Xospata (Gilteritinib) Covered by Humana in North Carolina Xospata requires prior authorization from Humana and is placed on the specialty drug tier. For approval, you need: (1) confirmed FLT3 mutation test results from an FDA-approved assay, (2) documented relapsed/refractory AML diagnosis, and (3) prior therapy history.

How to Get Waylivra (Volanesorsen) Covered by Cigna in North Carolina: Appeals Guide and Policy Details

Quick Answer: Waylivra Coverage with Cigna in North Carolina Waylivra (volanesorsen) is not FDA-approved in the U.S., making Cigna coverage extremely unlikely through standard pathways. Nearly all initial requests are denied as "experimental" or "not medically necessary." Your best options: 1) Request FDA-approved Tryngolza (olezarsen)